Establishment Labs (ESTA) Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings or view top-rated stocks.

5 brokerages have issued 12-month price objectives for Establishment Labs' shares. Their ESTA share price forecasts range from $65.00 to $110.00. On average, they predict the company's stock price to reach $95.20 in the next twelve months. This suggests a possible upside of 48.2% from the stock's current price.
View analysts price targets for ESTA or view top-rated stocks among Wall Street analysts.

Establishment Labs' stock was trading at $65.65 at the beginning of the year. Since then, ESTA shares have decreased by 2.1% and is now trading at $64.25.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our ESTA earnings forecast.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) released its earnings results on Monday, May, 8th. The company reported ($0.48) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.72) by $0.24. The firm had revenue of $46.52 million for the quarter, compared to the consensus estimate of $45.75 million. Establishment Labs had a negative net margin of 47.84% and a negative trailing twelve-month return on equity of 422.08%.

ETFs with the largest weight of Establishment Labs (NASDAQ:ESTA) stock in their portfolio include Simplify Health Care ETF (PINK), Nuveen Small Cap Select ETF (NSCS), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), iShares U.S. Small Cap Equity Factor ETF (SMLF), First Trust IPOX Europe Equity Opportunities ETF (FPXE),

Establishment Labs updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $200.00 million-$210.00 million, compared to the consensus revenue estimate of $206.10 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

(ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager.

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Establishment Labs' stock is owned by many different institutional and retail investors. Top institutional investors include RTW Investments LP (9.77%), Brown Advisory Inc. (6.06%), Cowen AND Company LLC (3.54%), Perceptive Advisors LLC (1.82%), Nicholas Investment Partners LP (1.87%) and UBS Group AG (1.58%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Renee Gaeta and Santos Salvador Dada.
View institutional ownership trends.

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ESTA stock can currently be purchased for approximately $64.25.

Establishment Labs (NASDAQ:ESTA) has a market capitalization of $1.65 billion and generates $161.70 million in revenue each year. The company earns $-75,210,000.00 in net income (profit) each year or ($3.31) on an earnings per share basis.

The company employs 746 workers across the globe.

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The official website for the company is www.establishmentlabs.com. The company can be reached via phone at (062) 434-2400 or via email at ir@establishmentlabs.com.